Crossref
Prevention of severe RSV-associated lower respiratory tract infections in children at high risk of RSV infection: use of palivizumab
Pharmateca · 24.04.2026 · 1_2026 · 90-95
DOI: 10.18565/pharmateca.2026.1.90-95 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmateca, erschienen am 24.04.2026. Verfasst von Borzakova S.N. Borzakova und 2 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Borzakova, B. S., Mikheeva, M. A., & Esmurzieva, E. Z. (2026). Prevention of severe RSV-associated lower respiratory tract infections in children at high risk of RSV infection: use of palivizumab. Pharmateca, 1_2026, 90-95. https://doi.org/10.18565/pharmateca.2026.1.90-95
Vancouver
Borzakova BS, Mikheeva MA, Esmurzieva EZ. Prevention of severe RSV-associated lower respiratory tract infections in children at high risk of RSV infection: use of palivizumab. Pharmateca. 2026;1_2026:90-95. doi:10.18565/pharmateca.2026.1.90-95
BibTeX
@article{Borzakova2026,
author = {Borzakova, Borzakova S.N. and Mikheeva, Mikheeva A.A. and Esmurzieva, Esmurzieva Z.I.},
title = {Prevention of severe RSV-associated lower respiratory tract infections in children at high risk of RSV infection: use of palivizumab},
journal = {Pharmateca},
year = {2026},
volume = {1_2026},
pages = {90--95},
doi = {10.18565/pharmateca.2026.1.90-95}
}
EUVIMED